Published in Proc Natl Acad Sci U S A on October 13, 2008
Somatic STAT3 mutations in large granular lymphocytic leukemia. N Engl J Med (2012) 4.15
Discrete logic modelling as a means to link protein signalling networks with functional analysis of mammalian signal transduction. Mol Syst Biol (2009) 2.98
How I treat LGL leukemia. Blood (2010) 2.38
Logic-based models for the analysis of cell signaling networks. Biochemistry (2010) 2.21
Boolean network simulations for life scientists. Source Code Biol Med (2008) 2.05
Toward the dynamic interactome: it's about time. Brief Bioinform (2010) 1.91
Discovery of somatic STAT5b mutations in large granular lymphocytic leukemia. Blood (2013) 1.80
The root of many evils: indolent large granular lymphocyte leukaemia and associated disorders. Hematol Oncol (2010) 1.67
Realistic control of network dynamics. Nat Commun (2013) 1.63
Multi-level modeling of light-induced stomatal opening offers new insights into its regulation by drought. PLoS Comput Biol (2014) 1.63
Cell fate reprogramming by control of intracellular network dynamics. PLoS Comput Biol (2015) 1.59
Training signaling pathway maps to biochemical data with constrained fuzzy logic: quantitative analysis of liver cell responses to inflammatory stimuli. PLoS Comput Biol (2011) 1.53
ON/OFF and beyond--a boolean model of apoptosis. PLoS Comput Biol (2009) 1.53
Dynamical and structural analysis of a T cell survival network identifies novel candidate therapeutic targets for large granular lymphocyte leukemia. PLoS Comput Biol (2011) 1.51
Mathematical modelling of cell-fate decision in response to death receptor engagement. PLoS Comput Biol (2010) 1.49
A molecular and functional analysis of large granular lymphocyte expansions in patients with chronic myelogenous leukemia treated with tyrosine kinase inhibitors. Leuk Lymphoma (2011) 1.47
Efficient experimental design for uncertainty reduction in gene regulatory networks. BMC Bioinformatics (2015) 1.45
NKp46 identifies an NKT cell subset susceptible to leukemic transformation in mouse and human. J Clin Invest (2011) 1.30
Pairing computation with experimentation: a powerful coupling for understanding T cell signalling. Nat Rev Immunol (2010) 1.25
The crosstalk between EGF, IGF, and Insulin cell signaling pathways--computational and experimental analysis. BMC Syst Biol (2009) 1.24
Platelet-derived growth factor mediates survival of leukemic large granular lymphocytes via an autocrine regulatory pathway. Blood (2009) 1.17
Modeling approaches for qualitative and semi-quantitative analysis of cellular signaling networks. Cell Commun Signal (2013) 1.17
The pathogenesis and treatment of large granular lymphocyte leukemia. Blood Rev (2014) 1.13
The duration of T cell stimulation is a critical determinant of cell fate and plasticity. Sci Signal (2013) 1.12
Elementary signaling modes predict the essentiality of signal transduction network components. BMC Syst Biol (2011) 1.04
Dynamical systems approach to endothelial heterogeneity. Circ Res (2012) 1.03
Identification of a topological characteristic responsible for the biological robustness of regulatory networks. PLoS Comput Biol (2009) 1.01
Understanding disease mechanisms with models of signaling pathway activities. BMC Syst Biol (2014) 1.00
Inference of Network Dynamics and Metabolic Interactions in the Gut Microbiome. PLoS Comput Biol (2015) 0.99
Immunosuppressive therapy of LGL leukemia: prospective multicenter phase II study by the Eastern Cooperative Oncology Group (E5998). Leukemia (2014) 0.98
Phase 1 trial of IL-15 trans presentation blockade using humanized Mikβ1 mAb in patients with T-cell large granular lymphocytic leukemia. Blood (2012) 0.93
Large granular lymphocyte leukemia: from dysregulated pathways to therapeutic targets. Future Oncol (2012) 0.93
The analysis of clonal diversity and therapy responses using STAT3 mutations as a molecular marker in large granular lymphocytic leukemia. Haematologica (2014) 0.91
Stabilization of perturbed Boolean network attractors through compensatory interactions. BMC Syst Biol (2014) 0.91
Logic-based models in systems biology: a predictive and parameter-free network analysis method. Integr Biol (Camb) (2012) 0.90
Mathematical biology modules based on modern molecular biology and modern discrete mathematics. CBE Life Sci Educ (2010) 0.90
Systems biology approaches for advancing the discovery of effective drug combinations. J Cheminform (2015) 0.90
Structural permeability of complex networks to control signals. Nat Commun (2015) 0.89
Increased serum soluble IL-15Rα levels in T-cell large granular lymphocyte leukemia. Blood (2011) 0.89
Simulating quantitative cellular responses using asynchronous threshold Boolean network ensembles. BMC Syst Biol (2011) 0.89
Sphingolipid signaling and hematopoietic malignancies: to the rheostat and beyond. Anticancer Agents Med Chem (2011) 0.88
Steady state analysis of Boolean molecular network models via model reduction and computational algebra. BMC Bioinformatics (2014) 0.88
Are T-LGL Leukemia and NK-Chronic Lymphoproliferative Disorder really two distinct diseases? Transl Med UniSa (2014) 0.87
Large granular lymphocyte disorders: new etiopathogenetic clues as a rationale for innovative therapeutic approaches. Haematologica (2009) 0.86
Control of complex networks requires both structure and dynamics. Sci Rep (2016) 0.85
Network model of immune responses reveals key effectors to single and co-infection dynamics by a respiratory bacterium and a gastrointestinal helminth. PLoS Comput Biol (2012) 0.85
Targeting sphingosine-1-phosphate in hematologic malignancies. Anticancer Agents Med Chem (2011) 0.85
Discovery of Drug Synergies in Gastric Cancer Cells Predicted by Logical Modeling. PLoS Comput Biol (2015) 0.84
Large granular lymphocytosis during dasatinib therapy. Cancer Biol Ther (2013) 0.84
NeuroDNet - an open source platform for constructing and analyzing neurodegenerative disease networks. BMC Neurosci (2013) 0.84
Logical Modeling and Dynamical Analysis of Cellular Networks. Front Genet (2016) 0.84
A geometrical approach to control and controllability of nonlinear dynamical networks. Nat Commun (2016) 0.83
Advanced systems biology methods in drug discovery and translational biomedicine. Biomed Res Int (2013) 0.82
Inferring the Effects of Honokiol on the Notch Signaling Pathway in SW480 Colon Cancer Cells. Cancer Inform (2014) 0.82
Cytokines as Adjuvants for Vaccine and Cellular Therapies for Cancer. Am J Immunol (2009) 0.81
Never say die: survival signaling in large granular lymphocyte leukemia. Clin Lymphoma Myeloma (2009) 0.81
Effects of Toll-like receptor signals in T-cell neoplasms. Future Oncol (2011) 0.79
Unraveling the complex regulatory relationships between metabolism and signal transduction in cancer. Adv Exp Med Biol (2012) 0.79
Sphingosine kinase 1 as an anticancer therapeutic target. Drug Des Devel Ther (2015) 0.79
Parameter-less approaches for interpreting dynamic cellular response. J Biol Eng (2014) 0.79
Molecular network control through boolean canalization. EURASIP J Bioinform Syst Biol (2015) 0.79
Querying quantitative logic models (Q2LM) to study intracellular signaling networks and cell-cytokine interactions. Biotechnol J (2012) 0.78
Nonparametric simulation of signal transduction networks with semi-synchronized update. PLoS One (2012) 0.78
Network modelling reveals the mechanism underlying colitis-associated colon cancer and identifies novel combinatorial anti-cancer targets. Sci Rep (2015) 0.78
Dynamics of DNA damage induced pathways to cancer. PLoS One (2013) 0.78
Proteins interaction network and modeling of IGVH mutational status in chronic lymphocytic leukemia. Theor Biol Med Model (2015) 0.77
Integrated network model provides new insights into castration-resistant prostate cancer. Sci Rep (2015) 0.77
MONOMIALS AND BASIN CYLINDERS FOR NETWORK DYNAMICS. SIAM J Appl Dyn Syst (2015) 0.77
Targeting IL-15 in large granular lymphocyte leukemia. Expert Rev Clin Immunol (2013) 0.77
Principles of dynamical modularity in biological regulatory networks. Sci Rep (2016) 0.77
Identification of Th1/Th2 regulatory switch to promote healing response during leishmaniasis: a computational approach. EURASIP J Bioinform Syst Biol (2015) 0.77
Fanconi anemia cells with unrepaired DNA damage activate components of the checkpoint recovery process. Theor Biol Med Model (2015) 0.76
Involvement of KRAS G12A mutation in the IL-2-independent growth of a human T-LGL leukemia cell line, PLT-2. Nagoya J Med Sci (2012) 0.76
COMPUTATIONAL METHODS FOR ASYNCHRONOUS BASINS. Discrete Continuous Dyn Syst Ser B (2016) 0.75
Estimating Propensity Parameters Using Google PageRank and Genetic Algorithms. Front Neurosci (2016) 0.75
Algorithmic Perspectives of Network Transitive Reduction Problems and their Applications to Synthesis and Analysis of Biological Networks. Biology (Basel) (2013) 0.75
Correlations in the degeneracy of structurally controllable topologies for networks. Sci Rep (2017) 0.75
Detection of monoclonal T populations in patients with KIR-restricted chronic lymphoproliferative disorder of NK cells. Haematologica (2014) 0.75
Identification of control targets in Boolean molecular network models via computational algebra. BMC Syst Biol (2016) 0.75
Towards targeted combinatorial therapy design for the treatment of castration-resistant prostate cancer. BMC Bioinformatics (2017) 0.75
Developing an in vitro model of T cell type of large granular lymphocyte leukemia. Leuk Res (2013) 0.75
HSP70 mediates survival in apoptotic cells-Boolean network prediction and experimental validation. Front Cell Neurosci (2015) 0.75
Therapeutic potential of targeting sphingosine kinases and sphingosine 1-phosphate in hematological malignancies. Leukemia (2016) 0.75
Dysregulated signaling, proliferation and apoptosis impact on the pathogenesis of TCRγδ+ T cell large granular lymphocyte leukemia. PLoS One (2017) 0.75
Intracellular and intercellular signaling networks in cancer initiation, development and precision anti-cancer therapy: RAS acts as contextual signaling hub. Semin Cell Dev Biol (2016) 0.75
Template-based intervention in Boolean network models of biological systems. EURASIP J Bioinform Syst Biol (2014) 0.75
Sphingosine kinase inhibitors decrease viability and induce cell death in natural killer-large granular lymphocyte leukemia. Cancer Biol Ther (2015) 0.75
Can the second law of thermodynamics hold in cell cultures? Front Genet (2015) 0.75
Tipifarnib-mediated suppression of T-bet-dependent signaling pathways. Cancer Immunol Immunother (2011) 0.75
Phenotypic and functional separation of memory and effector human CD8+ T cells. J Exp Med (1997) 8.59
Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev (1999) 8.36
Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin. Nat Immunol (2005) 8.27
Circuitry of nuclear factor kappaB signaling. Immunol Rev (2006) 6.49
NF-kappaB and the immune response. Oncogene (2006) 5.62
Novel inhibitors of cytokine-induced IkappaBalpha phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. J Biol Chem (1997) 5.14
CD8+ T-cell memory in tumor immunology and immunotherapy. Immunol Rev (2006) 4.49
Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression. J Clin Invest (2001) 3.79
Discovery and evaluation of inhibitors of human sphingosine kinase. Cancer Res (2003) 3.71
Predicting essential components of signal transduction networks: a dynamic model of guard cell abscisic acid signaling. PLoS Biol (2006) 3.53
Fatal leukemia in interleukin 15 transgenic mice follows early expansions in natural killer and memory phenotype CD8+ T cells. J Exp Med (2001) 2.96
Robustness and fragility of Boolean models for genetic regulatory networks. J Theor Biol (2005) 2.51
Silencing T-bet defines a critical role in the differentiation of autoreactive T lymphocytes. Immunity (2004) 2.24
Large granular lymphocyte leukemia. Oncologist (2006) 2.21
Bay 11-7082 inhibits transcription factor NF-kappaB and induces apoptosis of HTLV-I-infected T-cell lines and primary adult T-cell leukemia cells. Blood (2002) 1.97
Antitumor activity of sphingosine kinase inhibitors. J Pharmacol Exp Ther (2006) 1.88
T-bet controls autoaggressive CD8 lymphocyte responses in type 1 diabetes. J Exp Med (2004) 1.88
IL-15 mimics T cell receptor crosslinking in the induction of cellular proliferation, gene expression, and cytotoxicity in CD8+ memory T cells. Proc Natl Acad Sci U S A (2002) 1.69
T-bet, a Th1 transcription factor, is up-regulated in T cells from patients with aplastic anemia. Blood (2006) 1.64
Systems-level insights into cellular regulation: inferring, analysing, and modelling intracellular networks. IET Syst Biol (2007) 1.63
ERK couples chronic survival of NK cells to constitutively activated Ras in lymphoproliferative disease of granular lymphocytes (LDGL). Oncogene (2004) 1.56
Dysregulation of CD95/CD95 ligand-apoptotic pathway in CD3(+) large granular lymphocyte leukemia. Blood (1998) 1.52
Molecular profiling of LGL leukemia reveals role of sphingolipid signaling in survival of cytotoxic lymphocytes. Blood (2008) 1.45
The role of CD95 in the regulation of peripheral T-cell apoptosis. Immunol Rev (2003) 1.41
Phosphatidylinositol-3-phosphate kinase pathway activation protects leukemic large granular lymphocytes from undergoing homeostatic apoptosis. Blood (2006) 1.36
Pathologic clonal cytotoxic T-cell responses: nonrandom nature of the T-cell-receptor restriction in large granular lymphocyte leukemia. Blood (2005) 1.34
Platelets and inflammation: role of platelet-derived growth factor, adhesion molecules and histamine. Inflamm Res (1997) 1.33
Cytokine-independent growth and clonal expansion of a primary human CD8+ T-cell clone following retroviral transduction with the IL-15 gene. Blood (2007) 1.32
Antigen activation and impaired Fas-induced death-inducing signaling complex formation in T-large-granular lymphocyte leukemia. Blood (2007) 1.32
T-bet is essential for the progression of experimental autoimmune encephalomyelitis. Immunology (2006) 1.25
IL-15 is a growth factor and an activator of CD8 memory T cells. Ann N Y Acad Sci (2002) 1.15
Interleukin-15 triggers the proliferation and cytotoxicity of granular lymphocytes in patients with lymphoproliferative disease of granular lymphocytes. Blood (1997) 1.14
A novel method for signal transduction network inference from indirect experimental evidence. J Comput Biol (2007) 1.06
Constitutive expression of cytotoxic proteases and down-regulation of protease inhibitors in LGL leukemia. Int J Oncol (2003) 1.04
Constitutive production of proinflammatory cytokines RANTES, MIP-1beta and IL-18 characterizes LGL leukemia. Int J Oncol (2005) 1.02
NET-SYNTHESIS: a software for synthesis, inference and simplification of signal transduction networks. Bioinformatics (2007) 1.02
Platelet-derived growth factor is a potent biologic response modifier of T cells. J Exp Med (1991) 0.96
Anti-CD3 monoclonal antibody-mediated cytotoxicity occurs through an interleukin-2-independent pathway in CD3+ large granular lymphocytes. Blood (1990) 0.89
DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol (2003) 84.79
HIV envelope induces a cascade of cell signals in non-proliferating target cells that favor virus replication. Proc Natl Acad Sci U S A (2002) 17.22
Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol (2003) 9.08
Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer. Cancer Cell (2003) 8.11
Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury. Ann Intern Med (2008) 5.89
The medaka draft genome and insights into vertebrate genome evolution. Nature (2007) 5.77
Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J Clin Invest (2005) 5.51
Resequencing of 31 wild and cultivated soybean genomes identifies patterns of genetic diversity and selection. Nat Genet (2010) 5.20
Single-cell exome sequencing and monoclonal evolution of a JAK2-negative myeloproliferative neoplasm. Cell (2012) 5.16
Resequencing 50 accessions of cultivated and wild rice yields markers for identifying agronomically important genes. Nat Biotechnol (2011) 4.84
Essential regulation of cell bioenergetics by constitutive InsP3 receptor Ca2+ transfer to mitochondria. Cell (2010) 4.62
Cre/loxP-mediated inactivation of the murine Pten tumor suppressor gene. Genesis (2002) 4.23
Somatic STAT3 mutations in large granular lymphocytic leukemia. N Engl J Med (2012) 4.15
Maize HapMap2 identifies extant variation from a genome in flux. Nat Genet (2012) 3.74
Discovery and evaluation of inhibitors of human sphingosine kinase. Cancer Res (2003) 3.71
Predicting essential components of signal transduction networks: a dynamic model of guard cell abscisic acid signaling. PLoS Biol (2006) 3.53
Mechanistic rationale for inhibition of poly(ADP-ribose) polymerase in ETS gene fusion-positive prostate cancer. Cancer Cell (2011) 3.53
Gene expression and viral prodution in latently infected, resting CD4+ T cells in viremic versus aviremic HIV-infected individuals. Proc Natl Acad Sci U S A (2003) 3.47
Microarray results: how accurate are they? BMC Bioinformatics (2002) 3.23
Near linear time algorithm to detect community structures in large-scale networks. Phys Rev E Stat Nonlin Soft Matter Phys (2007) 3.19
Therapeutic target database update 2012: a resource for facilitating target-oriented drug discovery. Nucleic Acids Res (2011) 3.05
Amelioration of ischemic acute renal injury by neutrophil gelatinase-associated lipocalin. J Am Soc Nephrol (2004) 2.96
The endoplasmic reticulum gateway to apoptosis by Bcl-X(L) modulation of the InsP3R. Nat Cell Biol (2005) 2.94
PTEN negatively regulates neural stem cell self-renewal by modulating G0-G1 cell cycle entry. Proc Natl Acad Sci U S A (2005) 2.93
Proportion of different subtypes of stroke in China. Stroke (2003) 2.90
Extracting biological meaning from large gene lists with DAVID. Curr Protoc Bioinformatics (2009) 2.88
The genomic sequence of the Chinese hamster ovary (CHO)-K1 cell line. Nat Biotechnol (2011) 2.87
Draft genome of the wheat A-genome progenitor Triticum urartu. Nature (2013) 2.86
Genome sequence of foxtail millet (Setaria italica) provides insights into grass evolution and biofuel potential. Nat Biotechnol (2012) 2.82
Apatinib for chemotherapy-refractory advanced metastatic gastric cancer: results from a randomized, placebo-controlled, parallel-arm, phase II trial. J Clin Oncol (2013) 2.69
The PSA(-/lo) prostate cancer cell population harbors self-renewing long-term tumor-propagating cells that resist castration. Cell Stem Cell (2012) 2.69
Genetic characterization of Nipah virus, Bangladesh, 2004. Emerg Infect Dis (2005) 2.62
STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia. Blood (2012) 2.55
Robustness and fragility of Boolean models for genetic regulatory networks. J Theor Biol (2005) 2.51
MCUR1 is an essential component of mitochondrial Ca2+ uptake that regulates cellular metabolism. Nat Cell Biol (2012) 2.48
Sequencing and automated whole-genome optical mapping of the genome of a domestic goat (Capra hircus). Nat Biotechnol (2012) 2.45
Platelet glycoprotein Ibalpha forms catch bonds with human WT vWF but not with type 2B von Willebrand disease vWF. J Clin Invest (2008) 2.43
Conditional loss of PTEN leads to precocious development and neoplasia in the mammary gland. Development (2002) 2.42
RNA-seq analysis of prostate cancer in the Chinese population identifies recurrent gene fusions, cancer-associated long noncoding RNAs and aberrant alternative splicings. Cell Res (2012) 2.41
Mechanism of Ca2+ disruption in Alzheimer's disease by presenilin regulation of InsP3 receptor channel gating. Neuron (2008) 2.40
How I treat LGL leukemia. Blood (2010) 2.38
T-cell and natural killer-cell large granular lymphocyte leukemia neoplasias. Leuk Lymphoma (2011) 2.37
Multiple genes for essential-hypertension susceptibility on chromosome 1q. Am J Hum Genet (2006) 2.34
NKX3.1 stabilizes p53, inhibits AKT activation, and blocks prostate cancer initiation caused by PTEN loss. Cancer Cell (2006) 2.29
Large granular lymphocyte leukemia. Oncologist (2006) 2.21
Genetic control of rice plant architecture under domestication. Nat Genet (2008) 2.17
Electrical transport along bacterial nanowires from Shewanella oneidensis MR-1. Proc Natl Acad Sci U S A (2010) 2.17
Genome-wide association study in Han Chinese identifies four new susceptibility loci for coronary artery disease. Nat Genet (2012) 2.17
Use of mobile phones in an emergency reporting system for infectious disease surveillance after the Sichuan earthquake in China. Bull World Health Organ (2009) 2.11
Genome-wide identification of Francisella tularensis virulence determinants. Infect Immun (2007) 2.09
High prevalence of aeroallergen sensitization among infants of atopic parents. J Pediatr (2006) 2.08
PTEN dosage is essential for neurofibroma development and malignant transformation. Proc Natl Acad Sci U S A (2009) 2.07
Ulinastatin is a novel candidate drug for sepsis and secondary acute lung injury, evidence from an optimized CLP rat model. Int Immunopharmacol (2013) 2.06
Boolean network simulations for life scientists. Source Code Biol Med (2008) 2.05
Effectiveness of a combination therapy using calcineurin inhibitor and mTOR inhibitor in preventing allograft rejection and post-transplantation renal cancer progression. Cancer Lett (2012) 2.05
A critical role of erythropoietin receptor in neurogenesis and post-stroke recovery. J Neurosci (2006) 2.04
Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapy: a multicentre pharmacokinetic study. Crit Care Med (2012) 2.04
RPGR isoforms in photoreceptor connecting cilia and the transitional zone of motile cilia. Invest Ophthalmol Vis Sci (2003) 2.00
Extended applications of vascularized preauricular and helical rim flaps in reconstruction of nasal defects. Plast Reconstr Surg (2008) 1.98
Cigarette smoking, N-acetyltransferase 2 genotypes, and breast cancer risk: pooled analysis and meta-analysis. Cancer Epidemiol Biomarkers Prev (2008) 1.97
Novel cross talk of Kruppel-like factor 4 and beta-catenin regulates normal intestinal homeostasis and tumor repression. Mol Cell Biol (2006) 1.96
Major submissions tool developments at the European Nucleotide Archive. Nucleic Acids Res (2011) 1.94
Elevated phosphatidylinositol 3,4,5-trisphosphate in glia triggers cell-autonomous membrane wrapping and myelination. J Neurosci (2010) 1.93
Purple acid phosphatases of Arabidopsis thaliana. Comparative analysis and differential regulation by phosphate deprivation. J Biol Chem (2002) 1.93
Human immunodeficiency virus and hepatitis C infections induce distinct immunologic imprints in peripheral mononuclear cells. Hepatology (2009) 1.92
Nesfatin-1: distribution and interaction with a G protein-coupled receptor in the rat brain. Endocrinology (2007) 1.90
Ultrasound-mediated tumor imaging and nanotherapy using drug loaded, block copolymer stabilized perfluorocarbon nanoemulsions. J Control Release (2011) 1.89
Antitumor activity of sphingosine kinase inhibitors. J Pharmacol Exp Ther (2006) 1.88
Boolean modeling in systems biology: an overview of methodology and applications. Phys Biol (2012) 1.88
Androgen receptor-negative human prostate cancer cells induce osteogenesis in mice through FGF9-mediated mechanisms. J Clin Invest (2008) 1.87
Spatial distribution of soil heavy metal pollution estimated by different interpolation methods: accuracy and uncertainty analysis. Chemosphere (2010) 1.84
Blood pressure differences between northern and southern Chinese: role of dietary factors: the International Study on Macronutrients and Blood Pressure. Hypertension (2004) 1.84
Discovery of somatic STAT5b mutations in large granular lymphocytic leukemia. Blood (2013) 1.80
Deletion of the neuron-specific protein delta-catenin leads to severe cognitive and synaptic dysfunction. Curr Biol (2004) 1.80
Pten deletion in adult neural stem/progenitor cells enhances constitutive neurogenesis. J Neurosci (2009) 1.80
Control of petal shape and floral zygomorphy in Lotus japonicus. Proc Natl Acad Sci U S A (2006) 1.78
Kruppel-like factor 4 is acetylated by p300 and regulates gene transcription via modulation of histone acetylation. J Biol Chem (2007) 1.78
Pharmacological inhibition of the mammalian target of rapamycin pathway suppresses acquired epilepsy. Neurobiol Dis (2010) 1.75
Epoxyeicosanoids stimulate multiorgan metastasis and tumor dormancy escape in mice. J Clin Invest (2011) 1.74
Maternal embryonic leucine zipper kinase (MELK) regulates multipotent neural progenitor proliferation. J Cell Biol (2005) 1.74
Comparisons of image quality and radiation dose between iterative reconstruction and filtered back projection reconstruction algorithms in 256-MDCT coronary angiography. AJR Am J Roentgenol (2012) 1.73
3D noncontrast MR angiography of the distal lower extremities using flow-sensitive dephasing (FSD)-prepared balanced SSFP. Magn Reson Med (2009) 1.72
8q24 and prostate cancer: association with advanced disease and meta-analysis. Eur J Hum Genet (2008) 1.72
Mitomycin C-polyethylene glycol controlled-release film inhibits collagen secretion and induces apoptosis of fibroblasts in the early wound of a postlaminectomy rat model. Spine J (2010) 1.69
L-fucose utilization provides Campylobacter jejuni with a competitive advantage. Proc Natl Acad Sci U S A (2011) 1.68
Activation of β-catenin signaling in androgen receptor-negative prostate cancer cells. Clin Cancer Res (2012) 1.68
The root of many evils: indolent large granular lymphocyte leukaemia and associated disorders. Hematol Oncol (2010) 1.67
Integrated genomic analysis of relapsed childhood acute lymphoblastic leukemia reveals therapeutic strategies. Blood (2011) 1.67
Epoxy metabolites of docosahexaenoic acid (DHA) inhibit angiogenesis, tumor growth, and metastasis. Proc Natl Acad Sci U S A (2013) 1.66
GJB2 mutation spectrum in 2,063 Chinese patients with nonsyndromic hearing impairment. J Transl Med (2009) 1.66
Radiation dose reduction in computed tomography: techniques and future perspective. Imaging Med (2009) 1.65
Genetic background controls tumor development in PTEN-deficient mice. Cancer Res (2006) 1.63
Targeted indocyanine-green-loaded calcium phosphosilicate nanoparticles for in vivo photodynamic therapy of leukemia. ACS Nano (2011) 1.63
Telbivudine or lamivudine use in late pregnancy safely reduces perinatal transmission of hepatitis B virus in real-life practice. Hepatology (2014) 1.62
Contrast-enhanced whole-heart coronary magnetic resonance angiography at 3.0-T: a comparative study with X-ray angiography in a single center. J Am Coll Cardiol (2009) 1.61
Expansion of effector memory regulatory T cells represents a novel prognostic factor in lower risk myelodysplastic syndrome. J Immunol (2012) 1.61
Electromagnetic imaging methods for nondestructive evaluation applications. Sensors (Basel) (2011) 1.59